Harpreet Singh Bajaj, MD, MPH, an endocrinologist at LMC Diabetes & Endocrinology in Toronto, Canada, will present the primary results of the first phase 3 study of retatrutide in patients with type 2 diabetes, the TRANSCEND-T2D-1 trial
Using copper peptides alongside high-dose copper supplements
To evaluate the activity of pFeSAN to reaction temperature and pH, its oxidase-like activity was measured at various temperatures (10, 20, 30, 40, 50, 60, and 70 C) or medias with various pH values (2, 4, 6, 8, 10, and 12)
We look forward to connecting with you and sharing more about Astaphyll and our latest innovations
Farid M, Demicco EG, Garcia R, Ahn L, Merola PR, Cioffi A, et al
An orally-bioavailable glutathione-based Hepatoprotective compound in experimental acute liver injury: more effective than Silymarin and YHK